9-136196500-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_178138.6(LHX3):c.*825C>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00824 in 152,380 control chromosomes in the GnomAD database, including 29 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0082 ( 29 hom., cov: 33)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
LHX3
NM_178138.6 3_prime_UTR
NM_178138.6 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.579
Genes affected
LHX3 (HGNC:6595): (LIM homeobox 3) This gene encodes a member of a large family of proteins which carry the LIM domain, a unique cysteine-rich zinc-binding domain. The encoded protein is a transcription factor that is required for pituitary development and motor neuron specification. Mutations in this gene cause combined pituitary hormone deficiency 3. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 9-136196500-G-T is Benign according to our data. Variant chr9-136196500-G-T is described in ClinVar as [Benign]. Clinvar id is 365799.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0824 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LHX3 | NM_178138.6 | c.*825C>A | 3_prime_UTR_variant | 6/6 | ENST00000371748.10 | ||
LHX3 | NM_001363746.1 | c.*825C>A | 3_prime_UTR_variant | 6/6 | |||
LHX3 | NM_014564.5 | c.*825C>A | 3_prime_UTR_variant | 6/6 | |||
LHX3 | XM_017015168.1 | c.*825C>A | 3_prime_UTR_variant | 6/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LHX3 | ENST00000371748.10 | c.*825C>A | 3_prime_UTR_variant | 6/6 | 1 | NM_178138.6 | |||
LHX3 | ENST00000371746.9 | c.*825C>A | 3_prime_UTR_variant | 6/6 | 1 | P1 | |||
LHX3 | ENST00000619587.1 | c.*825C>A | 3_prime_UTR_variant | 6/6 | 1 | ||||
LHX3 | ENST00000645419.1 | n.2844C>A | non_coding_transcript_exon_variant | 5/5 |
Frequencies
GnomAD3 genomes AF: 0.00820 AC: 1249AN: 152262Hom.: 29 Cov.: 33
GnomAD3 genomes
AF:
AC:
1249
AN:
152262
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 436Hom.: 0 Cov.: 0 AF XY: 0.00 AC XY: 0AN XY: 254
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
436
Hom.:
Cov.:
0
AF XY:
AC XY:
0
AN XY:
254
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00824 AC: 1256AN: 152380Hom.: 29 Cov.: 33 AF XY: 0.0101 AC XY: 754AN XY: 74512
GnomAD4 genome
AF:
AC:
1256
AN:
152380
Hom.:
Cov.:
33
AF XY:
AC XY:
754
AN XY:
74512
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
241
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Non-acquired combined pituitary hormone deficiency with spine abnormalities Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at